Dr Anita Lim completed her BSc in pharmacology and MSc in clinical pharmacology at the University of Auckland (New Zealand).
She completed a PhD in cancer epidemiology under the supervision of Professors Peter Sasieni and Usha Menon at Queen Mary University of London.
Her thesis explored the potential for using symptoms to bring forward the diagnosis of ovarian cancer.
After her Phd, she led a project on delays in diagnosis of young women with cervical cancer at the Promoting Early Presentation Group, King's College London.
Her current research interests include self-sampled HPV testing and new screening technologies for cervical cancer.